Saltar al contenido principal
Etiqueta
Press Release

ObvioHealth Welcomes Scott Dixon as Chief Commercial Officer

ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next generation DCT platform and app.

Download the PDF

‍Executive with more than 25 years of health and technology experience joins growing VRO.

‍

‍NEW YORK, August 31, 2022 - ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app.  

‍

“ObvioHealth is empowering clinical trial sponsors to capture stronger evidence through its innovative use of technology,” said Dixon. “I’m truly excited to lead our commercial and strategic partnerships, as well as our experienced service and delivery teams, to help our clients adopt ObvioHealth’s cutting-edge, digital DCT solutions.”  

‍

During his 25+ year career, Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.  

‍

“We are ecstatic to bring Scott on board, and believe his multi-faceted experience across operations, product, and sales divisions will bring valuable expertise to ObvioHealth,” said Ivan Jarry, CEO of ObvioHealth. “We look forward to his contributions to our ambitious and strategic roadmap moving forward.”

‍

Press Release

ObvioHealth Welcomes Scott Dixon as Chief Commercial Officer

No items found.
Download the PDF

‍Executive with more than 25 years of health and technology experience joins growing VRO.

‍

‍NEW YORK, August 31, 2022 - ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app.  

‍

“ObvioHealth is empowering clinical trial sponsors to capture stronger evidence through its innovative use of technology,” said Dixon. “I’m truly excited to lead our commercial and strategic partnerships, as well as our experienced service and delivery teams, to help our clients adopt ObvioHealth’s cutting-edge, digital DCT solutions.”  

‍

During his 25+ year career, Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.  

‍

“We are ecstatic to bring Scott on board, and believe his multi-faceted experience across operations, product, and sales divisions will bring valuable expertise to ObvioHealth,” said Ivan Jarry, CEO of ObvioHealth. “We look forward to his contributions to our ambitious and strategic roadmap moving forward.”

‍

Press Release

ObvioHealth Welcomes Scott Dixon as Chief Commercial Officer

ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next generation DCT platform and app.

No items found.
Download the PDF

‍Executive with more than 25 years of health and technology experience joins growing VRO.

‍

‍NEW YORK, August 31, 2022 - ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app.  

‍

“ObvioHealth is empowering clinical trial sponsors to capture stronger evidence through its innovative use of technology,” said Dixon. “I’m truly excited to lead our commercial and strategic partnerships, as well as our experienced service and delivery teams, to help our clients adopt ObvioHealth’s cutting-edge, digital DCT solutions.”  

‍

During his 25+ year career, Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.  

‍

“We are ecstatic to bring Scott on board, and believe his multi-faceted experience across operations, product, and sales divisions will bring valuable expertise to ObvioHealth,” said Ivan Jarry, CEO of ObvioHealth. “We look forward to his contributions to our ambitious and strategic roadmap moving forward.”

‍

Press Release

ObvioHealth Welcomes Scott Dixon as Chief Commercial Officer

No items found.
Download the PDF

‍Executive with more than 25 years of health and technology experience joins growing VRO.

‍

‍NEW YORK, August 31, 2022 - ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app.  

‍

“ObvioHealth is empowering clinical trial sponsors to capture stronger evidence through its innovative use of technology,” said Dixon. “I’m truly excited to lead our commercial and strategic partnerships, as well as our experienced service and delivery teams, to help our clients adopt ObvioHealth’s cutting-edge, digital DCT solutions.”  

‍

During his 25+ year career, Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.  

‍

“We are ecstatic to bring Scott on board, and believe his multi-faceted experience across operations, product, and sales divisions will bring valuable expertise to ObvioHealth,” said Ivan Jarry, CEO of ObvioHealth. “We look forward to his contributions to our ambitious and strategic roadmap moving forward.”

‍

Press Release

ObvioHealth Welcomes Scott Dixon as Chief Commercial Officer

No items found.
Download the PDF

‍Executive with more than 25 years of health and technology experience joins growing VRO.

‍

‍NEW YORK, August 31, 2022 - ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app.  

‍

“ObvioHealth is empowering clinical trial sponsors to capture stronger evidence through its innovative use of technology,” said Dixon. “I’m truly excited to lead our commercial and strategic partnerships, as well as our experienced service and delivery teams, to help our clients adopt ObvioHealth’s cutting-edge, digital DCT solutions.”  

‍

During his 25+ year career, Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.  

‍

“We are ecstatic to bring Scott on board, and believe his multi-faceted experience across operations, product, and sales divisions will bring valuable expertise to ObvioHealth,” said Ivan Jarry, CEO of ObvioHealth. “We look forward to his contributions to our ambitious and strategic roadmap moving forward.”

‍

Press Release

ObvioHealth Welcomes Scott Dixon as Chief Commercial Officer

ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next generation DCT platform and app.

Download the PDF
No items found.

‍Executive with more than 25 years of health and technology experience joins growing VRO.

‍

‍NEW YORK, August 31, 2022 - ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app.  

‍

“ObvioHealth is empowering clinical trial sponsors to capture stronger evidence through its innovative use of technology,” said Dixon. “I’m truly excited to lead our commercial and strategic partnerships, as well as our experienced service and delivery teams, to help our clients adopt ObvioHealth’s cutting-edge, digital DCT solutions.”  

‍

During his 25+ year career, Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.  

‍

“We are ecstatic to bring Scott on board, and believe his multi-faceted experience across operations, product, and sales divisions will bring valuable expertise to ObvioHealth,” said Ivan Jarry, CEO of ObvioHealth. “We look forward to his contributions to our ambitious and strategic roadmap moving forward.”

‍

Back to Top
Press Release

ObvioHealth Welcomes Scott Dixon as Chief Commercial Officer

ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next generation DCT platform and app.

Download the PDF

‍Executive with more than 25 years of health and technology experience joins growing VRO.

‍

‍NEW YORK, August 31, 2022 - ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next-generation DCT platform and app.  

‍

“ObvioHealth is empowering clinical trial sponsors to capture stronger evidence through its innovative use of technology,” said Dixon. “I’m truly excited to lead our commercial and strategic partnerships, as well as our experienced service and delivery teams, to help our clients adopt ObvioHealth’s cutting-edge, digital DCT solutions.”  

‍

During his 25+ year career, Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.  

‍

“We are ecstatic to bring Scott on board, and believe his multi-faceted experience across operations, product, and sales divisions will bring valuable expertise to ObvioHealth,” said Ivan Jarry, CEO of ObvioHealth. “We look forward to his contributions to our ambitious and strategic roadmap moving forward.”

‍

Discover More Case Studies

Discover More News

Discover More White Papers

Discover More Blogs

Discover More Playbooks

Discover More Webinars

Discover More Events

No items found.

ObvioHealth Welcomes Richard Watkins as Chief Revenue Officer at a Pivotal Moment of Transformation

ObvioHealth welcomes sales veteran Richard Watkins as CRO to guide the company’s shift to enterprise software. His proven leadership in SaaS and healthcare will help expand ObvioGo® 2.0’s impact on clinical trials worldwide.

› Read More
No items found.

ObvioHealth Announces the Appointment of Nicholas Campbell to Its Board of Directors

ObvioHealth announces the appointment of seasoned healthcare executive Nicholas Campbell to its Board of Directors. Campbell brings expertise to accelerate digital innovation and advance clinical trial solutions.

› Read More